Silver Package All Access Pass

Sep 1, 2017

SILVER PACKAGE - $299
2015 & 2016 Recorded Conferences

• Access to 2015 recorded conferences until they expire
• Access to 2016 recorded conferences for 1 year from date of purchase
• Cost per credit as low as $0.47
• Valued at over $5,000
• Excludes Elsevier and Contraceptive Technology

Preview Available

Prescription Medications Issues: Polypharmacy, Drug Interactions and Compliance (Rx = .5 hr.) - Q&D (Rx = .25 hr.) - Faculty Panel

Apr 11, 2016 3:00pm ‐ Apr 11, 2016 3:45pm

Expiration Date: May 2, 2019

Learning Objectives:

• Describe MTM
• Discuss infertility
• Review urinary incontinence

• M. Hardy, MTM Pharmacist, PharmD, BCACP

Preview Available

Treatment of Anxiety and Depression in Women Over 40 (Rx = .5 hr.) - Q&D (Rx = .25 hr.) - Faculty Panel

Apr 11, 2016 3:45pm ‐ Apr 11, 2016 5:00pm

Expiration Date: May 2, 2019

Learning Objectives:

• Differentiate the presentation of the symptoms of anxiety disorders, depressive disorders and their overlap
• Analyze options in the treatment of anxiety disorders and depressive disorders
• Discuss options for treatment resistant symptoms of anxiety and depression

• Laura G. Leahy, DrNP(c), APRN, PMH-CNS/FNP, BC

Preview Available

Biology of Perimenopause and Menopause

Apr 12, 2016 8:00am ‐ Apr 12, 2016 9:00am

Learning Objectives:

• Council women about the endocrinologic changes that occur during perimenopause and menopause
• Describe how those changes can affect current symptomatology and long term health
• Explain how differences among women (weight, ethnicity, etc.) impacts on those changes

• Anita Nelson, MD

Preview Available

Vasomotor Symptoms: What Do We Have to Offer Women? (Rx = 1 hr.)

Apr 12, 2016 9:00am ‐ Apr 12, 2016 10:00am

Expiration Date: May 2, 2019

Learning Objectives:

• Display understanding of when to use a progestin as part of hormone therapy
• Demonstrate familiarity with available hormonal and non-hormonal treatments for menopause related vasomotor symptoms
• Identify common symptoms of menopause

• Patty Cason, MS, FNP-BC, Assistant Clinical Professor, UCLA School of Nursing, Nurse Practitioner & Consultant, Planned Parenthood, Los Angeles, California

Preview Available

GYN Cancer Screening and Prevention (Rx = .5 hr.)

Apr 12, 2016 2:00pm ‐ Apr 12, 2016 3:00pm

Expiration Date: May 2, 2019

Learning Objectives:

• Outline current recommendations for screening the general population for cervical, endometrial, ovarian and vulvar cancers
• Identify women who are at high risk for developing those cancers
• Describe interventions that can reduce those risks

• Anita Nelson, MD

Preview Available

Bioidentical Menopause Therapies

Apr 12, 2016 3:00pm ‐ Apr 12, 2016 4:00pm

Expiration Date: May 2, 2019

Learning Objectives:

• Define a bioidentical hormone
• Discuss risk of non FDA approved hormone therapy
• Provide information to patients on the availability of FDA approved bioidentical hormone therapy

• Julia A. Files, MD

Preview Available

10 Best Articles on Menopause 2015-2016 (Rx = .25 hr.)

Apr 13, 2016 8:00am ‐ Apr 13, 2016 9:00am

Expiration Date: May 2, 2019

Learning Objectives:

• Describe any new interpretations of WHI including data collected following initial study
• Define new syndromes, such as “GUMS” and explain why they have been developed
• Summarize new developments in topics that affect postmenopausal women, such as osteoporosis, sexual dysfunction, cardiovascular disease, etc

• Anita Nelson, MD

Preview Available

Osteoporosis: Diagnosis and Treatment (Rx = .25 hr.)

Apr 13, 2016 8:00am ‐ Apr 13, 2016 9:00am

Expiration Date: May 2, 2019

Learning Objectives:

• Be aware of current osteoporosis screening guidelines for women
• Describe how to monitor osteoporosis in women
• Discuss risks and benefits of osteoporosis pharmacotherapy

• Carolyn Crandall, MD, MS

Preview Available

Fertility Control in the Perimenopausal Years? (Rx = .75 hr.)

Apr 13, 2016 8:00am ‐ Apr 13, 2016 9:00am

Expiration Date: May 2, 2019

Learning Objectives:

• Describe 3 non-contraceptive benefits that could be beneficial for a perimenopausal woman
• Identify 2 considerations when counseling perimenopausal women about contraception
• Display familiarity with use of the 2010 CDC US Medical Eligibility for Contraceptive Use

• Patty Cason, MS, FNP-BC, Assistant Clinical Professor, UCLA School of Nursing, Nurse Practitioner & Consultant, Planned Parenthood, Los Angeles, California

Preview Available

Mechanisms and Management of Urinary Incontinence (Rx = .5 hr.)

Apr 13, 2016 8:00am ‐ Apr 13, 2016 9:00am

Expiration Date: May 2, 2019

Learning Objectives:

• List the types of established urinary incontinence
• Describe the evaluation of a patient with urinary incontinence
• Describe the treatment options available for each type of incontinence

• Darryl Chutka, MD